Stock Based Compensation (Tables)

6 Months Ended

Mar. 31, 2018

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense for the three and six months ended March 31, 2018 and 2017 is as follows:

	Three Months Ended		Three Months Ended
	March 31, 2018		March 31, 2017
Stock Grants	$	92,000	$	84,000
Restricted Stock Grants		13,000		13,000
Option Grants		4,000		13,000
Employee Stock Purchase Plan		1,000		1,000
Subsidiary Option Grants		28,000		28,000
Total	$	138,000	$	139,000

	Six Months Ended		Six Months Ended
	March 31, 2018		March 31, 2017
Stock Grants	$	130,000	$	123,000
Restricted Stock Grants		26,000		26,000
Option Grants		17,000		25,000
Employee Stock Purchase Plan		1,000		1,000
Subsidiary Option Grants		56,000		52,000
Total	$	230,000	$	227,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the six months ended March 31, 2018 is presented below:

Restricted Stock Activity for the Six Months ended March 31, 2018	Shares		Weighted-Average  Grant-Date Fair Value
Nonvested at September 30, 2017		70,000	$	1.73
Granted		-		-
Vested		(30,000)		1.73
Cancelled		-		-
Nonvested and expected to vest at March 31, 2018		40,000	$	1.73

Stock Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the six months ended March 31, 2018, no Dynasil stock options were granted. A summary of stock option activity for the six months ended March 31, 2018 is presented below:

	Options  Outstanding		Weighted Average  Exercise Price per  Share		Weighted Average  Remain Contractual Term (in Years)
Balance at September 30, 2017		196,769	$	1.98		1.64
Outstanding and exercisable at September 30, 2017		196,769	$	1.98		1.64
Granted		-		-
Exercised		-		-
Cancelled		(36,232)		1.82
Balance at March 31, 2018		160,537	$	2.01		1.43
Outstanding and exercisable at March 31, 2018		160,537	$	2.01		1.43

Subsidiary Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the three months ended March 31, 2018, no Xcede stock options were granted. A summary of Xcede stock option activity for the six months ended March 31, 2018 is presented below:

	Options  Outstanding		Weighted Average  Exercise Price per  Share		Weighted Average  Remain Contractual  Term (in Years)
Balance at September 30, 2017		1,375,956	$	1.00		8.70
Outstanding and exercisable at September 30, 2017		923,617		1.00		8.30
Granted		-		-
Exercised		-		-
Cancelled		-		-
Balance at March 31, 2018		1,375,956		1.00		8.18
Outstanding and exercisable at March 31, 2018		1,116,036	$	1.00		7.91